Primary Familial Polycythemia Due to Epo Receptor Mutation has an emerging clinical trial program.
Recruiting
Active Trials
2 additional trials involve behavioral, dietary, diagnostic, or observational approaches.
2 trials are observational or have no phase designation.
Trials often recruit across multiple countries, so totals exceed the trial count.
No trials match the current filters.
Stay informed about clinical trials for Primary Familial Polycythemia Due to Epo Receptor Mutation.
Follow this disease to get updates when trials open, close, or change status.
Already have an account? Sign in to manage your watchlists.
Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.
Last sync: March 20, 2026 at 4:50 PM